Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Schulkens IA"'
Autor:
Sanjurjo L; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schulkens IA; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Touarin P; Laboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), Institut de Microbiologie de la Méditerranée (IMM), CNRS - Aix-Marseille Université, UMR7255, Marseille, France., Heusschen R; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Aanhane E; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Castricum KCM; Amsterdam UMC location VUmc, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., De Gruijl TD; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Nilsson UJ; Lund University, Department of Chemistry, Centre for Analysis and Synthesis, Lund, Sweden., Leffler H; Lund University, Department of Laboratory Medicine, Section MIG, Lund, Sweden., Griffioen AW; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Elantak L; Laboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), Institut de Microbiologie de la Méditerranée (IMM), CNRS - Aix-Marseille Université, UMR7255, Marseille, France., Koenen RR; Maastricht University, Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands., Thijssen VLJL; Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands. v.thijssen@amsterdamumc.nl.; Amsterdam UMC location VUmc, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands. v.thijssen@amsterdamumc.nl.
Publikováno v:
Communications biology [Commun Biol] 2021 Dec 20; Vol. 4 (1), pp. 1415. Date of Electronic Publication: 2021 Dec 20.
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Autor:
Dulla K; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Slijkerman R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Diepen HC; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Albert S; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Dona M; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Beumer W; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Turunen JJ; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Chan HL; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schulkens IA; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Vorthoren L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., den Besten C; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Buil L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schmidt I; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Miao J; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Venselaar H; Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Zang J; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Neuhauss SCF; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Peters T; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Broekman S; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Pennings R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Kremer H; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Platenburg G; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Adamson P; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands; UCL, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK., de Vrieze E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Wijk E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands. Electronic address: erwin.vanwyk@radboudumc.nl.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Aug 04; Vol. 29 (8), pp. 2441-2455. Date of Electronic Publication: 2021 Apr 23.
Autor:
Goedegebuure RSA; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kleibeuker EA; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Buffa FM; Department of Molecular Oncology, University of Oxford, Oxford, UK., Castricum KCM; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Haider S; Department of Molecular Oncology, University of Oxford, Oxford, UK., Schulkens IA; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Ten Kroode L; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., van den Berg J; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Jacobs MAJM; Department of Gastroenterology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., van Berkel AM; Department of Gastroenterology, Noord West Ziekenhuisgroep, Alkmaar, The Netherlands., van Grieken NCT; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Derks S; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Slotman BJ; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Verheul HMW; Department of Medical Oncology, Radboud UMC, Nijmegen, The Netherlands., Harris AL; Department of Molecular Oncology, University of Oxford, Oxford, UK., Thijssen VL; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands. v.thijssen@amsterdamumc.nl.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 May 08; Vol. 40 (1), pp. 161. Date of Electronic Publication: 2021 May 08.
Autor:
Li, Jinhu1 (AUTHOR), Wang, Dongfang1 (AUTHOR) wangdf19@pku.edu.cn, Tang, Fei1,2 (AUTHOR), Ling, Xinnan1 (AUTHOR), Zhang, Wenjie1 (AUTHOR), Zhang, Zemin1,2 (AUTHOR) zemin@pku.edu.cn
Publikováno v:
National Science Review. Sep2024, Vol. 11 Issue 9, p1-16. 16p.
Autor:
Aanhane E; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands., Schulkens IA; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.; Angiogenesis Laboratory, Department of Radiation Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands., Heusschen R; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.; Laboratory of Hematology, GIGA-Research, University of Liège, Liege, Belgium., Castricum K; Angiogenesis Laboratory, Department of Radiation Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands., Leffler H; Section Microbiology, Immunology, Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden., Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands., Thijssen VL; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands. v.thijssen@vumc.nl.; Angiogenesis Laboratory, Department of Radiation Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands. v.thijssen@vumc.nl.
Publikováno v:
Angiogenesis [Angiogenesis] 2018 Aug; Vol. 21 (3), pp. 545-555. Date of Electronic Publication: 2018 Mar 02.
Autor:
Kleibeuker EA; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands.; Department of Medical Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Fokas E; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Allen PD; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Kersemans V; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Griffioen AW; Department of Medical Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Beech J; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Im JH; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Smart SC; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Castricum KC; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., van den Berg J; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Schulkens IA; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Hill SA; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Harris AL; Department of Molecular Oncology, University of Oxford, Oxford, UK., Slotman BJ; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Verheul HM; Department of Medical Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands., Muschel RJ; Oxford Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK., Thijssen VL; Department of Radiation Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands.; Department of Medical Oncology, VU University Medical Centre, De Boelelaan, HV Amsterdam, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2016 Nov 22; Vol. 7 (47), pp. 76613-76627.
Autor:
van Beijnum JR; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Thijssen VL; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Läppchen T; Oncology Solutions, Philips Research, Eindhoven, the Netherlands.; Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany., Wong TJ; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Verel I; Oncology Solutions, Philips Research, Eindhoven, the Netherlands., Engbersen M; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Schulkens IA; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Rossin R; Oncology Solutions, Philips Research, Eindhoven, the Netherlands., Grüll H; Oncology Solutions, Philips Research, Eindhoven, the Netherlands., Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Nowak-Sliwinska P; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2016 Aug 15; Vol. 139 (4), pp. 824-35. Date of Electronic Publication: 2016 May 05.
Autor:
Punt S; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. B.S.Punt@lumc.nl., Houwing-Duistermaat JJ; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands. J.J.Houwing@lumc.nl., Schulkens IA; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, De Boelelaan 1118, 1081HV, Amsterdam, The Netherlands. I.Schulkens@vumc.nl., Thijssen VL; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, De Boelelaan 1118, 1081HV, Amsterdam, The Netherlands. V.Thijssen@vumc.nl., Osse EM; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. E.M.Osse@lumc.nl., de Kroon CD; Department of Gynaecology, Leiden University Medical Center, Leiden, The Netherlands. C.D.de_Kroon@lumc.nl., Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, De Boelelaan 1118, 1081HV, Amsterdam, The Netherlands. A.Griffioen@vumc.nl., Fleuren GJ; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. G.J.Fleuren@lumc.nl., Gorter A; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. A.Gorter@lumc.nl., Jordanova ES; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. E.S.Jordanova@lumc.nl.; Center for Gynecological Oncology Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. E.S.Jordanova@lumc.nl.
Publikováno v:
Molecular cancer [Mol Cancer] 2015 Mar 31; Vol. 14, pp. 71. Date of Electronic Publication: 2015 Mar 31.
Autor:
Kleibeuker EA; Angiogenesis Laboratory Amsterdam, Department of Radiation Oncology, VU University medical center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Schulkens IA, Castricum KC, Griffioen AW, Thijssen VL
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2015; Vol. 1207, pp. 305-15.
Autor:
Schulkens IA; Angiogenesis Laboratory Amsterdam, Department of Medical Oncology, VU University medical center, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Kleibeuker EA, Castricum KC, Griffioen AW, Thijssen VL
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2015; Vol. 1207, pp. 285-91.